In biowin's link to CSCS's post dated January 23, 2019, it clearly specified that BioAmber, Inc., still owned all the patents. BioAmber, Inc., the U.S. based home company had a filing for bankruptcy DISMISSED in October, 2018. In the same month, according to the NaySayers, "all BioAmber assets" were liquidated in a final deal for $4.34M, OK'd by Judge Pinnsonault.
Where's the contradiction?
1. The "deal" was done.
2. The "shares were safe."
3. BioAmber, Inc., held onto all the patents, pending the financial restructuring.
4. KKR was the owner of the last resort of the Sarnia Plant, after playing Angel financier for LCY BioSciences.
We might ask: What did LCY BioSciences do with the $1.56B proffered by KKR in the summer of 2018? We can surmise that there's a second plant operating outside the USA. I haven't done the research on this. Isn't Thailand the location of the second plant? Just asking.
I think we can assume that our shares are safe. CSCS, biowin, and others have provided the information and the data to back up these conclusions.
Meanwhile, in an iron-eagle post of June 14, 2023, he lists a section from the 9th PWC report, which indicates, "certain employees at BioAmber" were retained to assist with issues "relating to the ... sale of the Company." When were these costs incurred? Just askin'. Were "certain employees" helpful in setting up operations at a second plant? If after October 2018 ... we can deduce that the sale wasn't completed. That says a lot.
As everyone knows, there's been a lot going on in the world for the last three years or more. When the dust settles, I think we can be sure of this: Green, biodegradable technologies will be riding high on the waves, and BioAmber will be right there in the lead group. Those who held onto their shares will have good reason to celebrate.
AI
